StonvexLoading…
StonvexStonvexStonvexCore line items from AVD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $515.11M | $547.31M | $579.37M | $609.62M |
Operating Income | $-28.30M | $-101.56M | $23.30M | $40.65M |
Net Income | $-49.88M | $-126.34M | $7.52M | $27.40M |
EPS (Diluted) | $-1.75 | $-4.50 | $0.26 | $0.92 |
Total Assets | $596.54M | $636.72M | $767.55M | $726.31M |
Total Liabilities | $404.14M | $403.61M | $397.54M | $356.33M |
Cash & Equivalents | $12.43M | $12.51M | $11.42M | $20.33M |
Free Cash Flow OCF − CapEx | $-25.11M | $-3.36M | $-70.63M | $43.84M |
Shares Outstanding | 28.43M | 28.06M | 28.53M | 29.87M |